Credit: Wild Awake/Adobe Stock
As we know from recent research conducted by the National Institutes of Health, gastrointestinal (GI) conditions remain highly prevalent in the U.S., with 61% of Americans, or nearly 2 in 3, reporting experiencing a GI issue at least once per week. Painful GI symptoms can result from a multitude of things: an unknown allergy, undiagnosed digestive disorder like IBS, GERD or IBD, stress, traveling, or simply not exercising enough. Now, providers and employers are also dealing with GI side effects from popular GLP-1 medications, which are used to treat type 2 diabetes and weight loss. While these drugs have helped millions of Americans overcome the detrimental effects of obesity and diabetes, the digestive symptoms associated with their use have been shown to significantly impact quality of life, creating knock-on effects and costs for employers.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
